GO:0015379 potassium:chloride symporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015379 defines potassium:chloride symporter activity, a molecular function that couples the inward movement of K+ and Cl- across a membrane.
• The best-characterized K+:Cl- symporters are the SLC12A family members KCC1, KCC2, KCC3, and KCC4, which are electroneutral cotransporters.
• KCC2 is neuron-specific and is essential for maintaining low intracellular Cl- in mature neurons, thereby enabling fast inhibitory neurotransmission.
• KCC2 activity and surface stability are regulated by protein kinase C-dependent phosphorylation, which reduces its transport capacity.
• Dysregulation of K+:Cl- symport is linked to neurological disorders, hypertension, and epithelial transport diseases.
• CRISPR-based knockout, point mutation, and knock-in models are powerful tools to dissect the physiological roles of K+:Cl- symporter genes.
Description
Potassium:chloride symporter activity (GO:0015379) is a molecular function that mediates the coupled, electroneutral transport of potassium (K+) and chloride (Cl-) ions across biological membranes. This activity is fundamental to cellular ion homeostasis, cell volume regulation, and the modulation of electrical signaling in excitable cells. The reaction catalyzed by these symporters moves one K+ and one Cl- ion in the same direction, typically into the cell, without generating a net current. Because of their role in setting the intracellular chloride concentration, K+:Cl- symporters are particularly important in neurons, where they determine the strength and polarity of GABAergic and glycinergic inhibition. In epithelial tissues, they contribute to transepithelial salt and water transport. Researchers study GO:0015379 to understand how ion gradients are established and maintained, and how their disruption leads to diseases such as epilepsy, neuropathic pain, and hypertension. The molecular players, regulatory mechanisms, and disease associations of this activity are the focus of intense investigation, with CRISPR-based models offering precise tools to probe gene function.
potassium:chloride symporter activity At A Glance
| GO ID | GO:0015379 |
|---|---|
| GO term | potassium:chloride symporter activity |
| Ontology | molecular_function |
| Synonym | potassium ion symporter activity |
| Definition | Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: K+(out) + Cl-(out) = K+(in) + Cl-(in). |
| Major function | Electroneutral coupled transport of K+ and Cl- across membranes, contributing to ion homeostasis, cell volume regulation, and neuronal inhibition. |
| Representative genes | SLC12A1 (NKCC2), SLC12A2 (NKCC1), SLC12A3 (NCC), SLC12A4 (KCC1), SLC12A5 (KCC2), SLC12A6 (KCC3), SLC12A7 (KCC4) |
| Cellular location | Plasma membrane of various cell types, including neurons and epithelial cells. |
| Regulatory mechanism | Phosphorylation by kinases such as protein kinase C (PKC) modulates transporter activity and surface stability. |
What Is GO:0015379?
According to the Gene Ontology, GO:0015379 (potassium:chloride symporter activity) enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: K+(out) + Cl-(out) = K+(in) + Cl-(in). In other words, it is a secondary active transport process that couples the movement of potassium and chloride ions in the same direction across a lipid bilayer, without directly consuming ATP. This activity is distinct from ion channels, which allow passive diffusion, and from exchangers, which move ions in opposite directions.
Why Is potassium:chloride symporter activity Important in Cell Biology?
Potassium:chloride symporter activity is critical for maintaining the electrochemical gradients of K+ and Cl- across cell membranes, which underlies fundamental processes such as neuronal excitability, cell volume regulation, and epithelial salt transport. Dysfunction of these transporters has been implicated in a wide range of human diseases, including epilepsy, neuropathic pain, hypertension, and hearing loss. Understanding the molecular mechanisms and regulation of GO:0015379 is therefore essential for developing targeted therapies and for interpreting genetic variants associated with these disorders.
• Maintains low intracellular Cl- in mature neurons, which is required for fast inhibitory neurotransmission mediated by GABA and glycine.
• Regulates cell volume in response to osmotic stress, protecting cells from swelling or shrinkage.
• Contributes to transepithelial ion transport in kidney, salivary gland, and other epithelia.
• Mutations in K+:Cl- symporter genes are associated with neurological disorders such as epilepsy and peripheral neuropathy.
• Altered K+:Cl- symport activity is linked to hypertension and electrolyte imbalances.
• Serves as a target for pharmacological modulation, including diuretics and potential neuroprotective agents.
• Plays a role in chloride metabolism in halophilic prokaryotes, indicating evolutionary conservation.
• Provides a paradigm for studying secondary active transport and ion coupling mechanisms.
• Enables the development of CRISPR-based disease models to test causal relationships.
• Informs the design of synthetic ion receptors and transporters for biomedical applications.
Mechanism, Genes and Research Methods of potassium:chloride symporter activity
Biological Process: What Happens During potassium:chloride symporter activity?
In simple terms: In simple terms, the symporter grabs one potassium ion and one chloride ion from outside the cell and carries them together into the cell.
The biological process mediated by GO:0015379 is the coupled translocation of K+ and Cl- across the plasma membrane. This transport is electroneutral, meaning it does not change the membrane potential directly. In neurons, the inward movement of Cl- via KCC2 lowers the intracellular Cl- concentration, which is essential for the hyperpolarizing action of GABA and glycine. In epithelial cells, K+:Cl- symporters contribute to salt and water transport, influencing processes such as saliva formation and renal ion handling. The activity is driven by the combined electrochemical gradients of K+ and Cl-, which are maintained by other transporters and channels.
Cellular Component: Structure and Composition of potassium:chloride symporter activity
In simple terms: The symporter is a protein machine embedded in the cell membrane that changes shape to move ions.
K+:Cl- symporters are integral membrane proteins belonging to the SLC12A family of cation-chloride cotransporters. They typically consist of 12 transmembrane domains with intracellular N- and C-termini. The functional unit is a monomer or possibly a dimer, and the protein is localized to the plasma membrane. The structure includes binding sites for K+ and Cl- that are alternately exposed to the extracellular and intracellular sides during the transport cycle. Regulatory domains in the C-terminus are subject to phosphorylation, which controls transporter trafficking and activity.
Molecular Function: Molecular Mechanism of potassium:chloride symporter activity
In simple terms: The symporter uses the energy stored in ion gradients to move both ions together, without burning ATP directly.
The molecular mechanism of GO:0015379 involves the simultaneous binding of one K+ and one Cl- ion to the transporter, followed by a conformational change that exposes the ions to the cytoplasm. This is a secondary active transport process, as it utilizes the electrochemical gradient of K+ (and Cl-) established by primary active transporters such as the Na+/K+-ATPase. The transport is electroneutral because the positive charge of K+ is balanced by the negative charge of Cl-. The activity can be regulated by phosphorylation; for example, protein kinase C-dependent phosphorylation of KCC2 reduces its cell surface stability and transport activity.
Regulation of potassium:chloride symporter activity
In simple terms: Cells can turn the symporter on or off by adding chemical tags, such as phosphate groups, to the protein.
The activity of K+:Cl- symporters is tightly regulated by phosphorylation and dephosphorylation events. Protein kinase C (PKC) phosphorylates KCC2 at specific residues, leading to reduced surface expression and decreased transport activity. This regulation is crucial for dynamic control of neuronal inhibition and cell volume. Other kinases, such as WNK kinases and SPAK/OSR1, also modulate the activity of SLC12A family members, although their specific effects on K+:Cl- symporters may vary. Hormones and osmotic stress can influence these regulatory pathways, thereby adjusting ion transport to physiological demands.
Key Genes Involved in GO:0015379 potassium:chloride symporter activity
The following genes encode proteins that exhibit potassium:chloride symporter activity or are closely related to this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC12A4 (KCC1) | Mediates K+:Cl- cotransport; involved in cell volume regulation | Studied in red blood cells and epithelial cells; knockout models show altered volume regulation |
| SLC12A5 (KCC2) | Neuron-specific K+:Cl- cotransporter; maintains low intracellular Cl- | Critical for inhibitory neurotransmission; mutations linked to epilepsy and neuropathic pain |
| SLC12A6 (KCC3) | K+:Cl- cotransporter in neurons and other tissues | Associated with peripheral neuropathy and agenesis of the corpus callosum |
| SLC12A7 (KCC4) | K+:Cl- cotransporter in kidney and inner ear | Involved in hearing and renal function; knockout mice exhibit deafness |
| SLC12A1 (NKCC2) | Na+-K+-2Cl- cotransporter; not a K+:Cl- symporter but related | Target of loop diuretics; mutations cause Bartter syndrome |
| SLC12A2 (NKCC1) | Na+-K+-2Cl- cotransporter; related to K+:Cl- symport | Implicated in neuronal development and pain |
| SLC12A3 (NCC) | Na+-Cl- cotransporter; related to K+:Cl- symport | Target of thiazide diuretics; mutations cause Gitelman syndrome |
| SLC12A8 | Putative cation-chloride cotransporter | Less characterized; potential role in ion transport |
| SLC12A9 | Putative cation-chloride cotransporter | Under investigation for roles in cell volume and ion homeostasis |
| WNK1 | Kinase that regulates SLC12A transporters | Modulates K+:Cl- symporter activity via phosphorylation cascades |
| WNK3 | Kinase that regulates SLC12A transporters | Influences KCC activity and neuronal chloride homeostasis |
| SPAK (STK39) | Downstream kinase in WNK signaling | Phosphorylates and regulates cation-chloride cotransporters |
| OSR1 (OXSR1) | Downstream kinase in WNK signaling | Regulates ion transport and cell volume |
| PPP1R1A (DARPP-32) | Phosphatase inhibitor | May modulate dephosphorylation of KCC2 |
| PKC (PRKCA) | Protein kinase C alpha | Phosphorylates KCC2, reducing its activity and surface stability |
| BDNF | Neurotrophic factor | Regulates KCC2 expression and function in neurons |
| GABA-A receptor subunits | Mediate inhibitory neurotransmission | Their function depends on KCC2-mediated Cl- gradient |
| Glycine receptors | Mediate inhibitory neurotransmission in spinal cord | Require low intracellular Cl- maintained by KCC2 |
How Is potassium:chloride symporter activity Regulated?
The activity of potassium:chloride symporters is regulated at multiple levels, including gene expression, alternative splicing, phosphorylation, and protein trafficking. Protein kinase C (PKC)-dependent phosphorylation of KCC2 at serine and threonine residues reduces its cell surface stability and transport activity, providing a rapid mechanism to modulate neuronal inhibition. The WNK-SPAK/OSR1 kinase cascade is a central regulator of SLC12A family members, although its specific effects on K+:Cl- symporters can vary depending on the cellular context. Additionally, osmotic stress and cell volume changes can influence the activity and expression of these transporters to maintain cellular homeostasis. Hormonal signals, such as aldosterone and vasopressin, may also affect K+:Cl- symport indirectly through electrolyte balance.
potassium:chloride symporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC12A5 (KCC2) | Epilepsy, neuropathic pain, spasticity | Knockout mouse, point mutation knock-in for phosphorylation sites |
| SLC12A6 (KCC3) | Peripheral neuropathy with agenesis of the corpus callosum | Knockout mouse, patient-derived iPSCs |
| SLC12A7 (KCC4) | Hearing loss, renal tubular acidosis | Knockout mouse, conditional knockout in inner ear |
| SLC12A4 (KCC1) | Red blood cell volume regulation disorders | Knockout mouse, overexpression in erythroid cells |
| SLC12A1 (NKCC2) | Bartter syndrome | Knockout mouse, knock-in of patient mutations |
Neurological Disorders
Dysfunction of K+:Cl- symporters, particularly KCC2 (SLC12A5), is implicated in epilepsy, neuropathic pain, and spasticity. Loss of KCC2 function leads to elevated intracellular Cl- in neurons, which can convert GABAergic inhibition into excitation, contributing to seizure activity. Mutations in SLC12A6 (KCC3) cause peripheral neuropathy with agenesis of the corpus callosum, a severe neurological disorder. These findings highlight the importance of K+:Cl- symport in maintaining normal brain function.
Hypertension and Renal Disorders
Altered activity of cation-chloride cotransporters, including K+:Cl- symporters, has been linked to hypertension and electrolyte imbalances. For example, mutations in SLC12A3 (NCC) cause Gitelman syndrome, characterized by hypokalemia and metabolic alkalosis, while SLC12A1 (NKCC2) mutations lead to Bartter syndrome. Although these are not K+:Cl- symporters, they illustrate the broader importance of this transporter family in renal salt handling. K+:Cl- symporters such as KCC4 (SLC12A7) are also expressed in the kidney and may contribute to renal function.
Epithelial Transport Disorders
K+:Cl- symporters play a role in transepithelial ion transport in salivary glands, airways, and other epithelia. Disruption of these transporters can affect fluid secretion and electrolyte composition, potentially contributing to diseases such as cystic fibrosis-like syndromes or salivary gland dysfunction. Understanding the specific contributions of K+:Cl- symporters in these tissues is an active area of research.
From potassium:chloride symporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KCC2 function alter neuronal inhibition? | CRISPR knockout of SLC12A5 in cultured neurons or mouse brain |
| How does phosphorylation of KCC2 regulate its activity? | Point mutation knock-in of phospho-deficient or phospho-mimetic residues |
| What is the effect of a disease-associated mutation in SLC12A6? | Knock-in of the patient mutation in mouse or iPSCs |
| Can overexpression of KCC2 rescue Cl- homeostasis? | Overexpression of SLC12A5 in neurons or cell lines |
| How does KCC4 contribute to hearing? | Conditional knockout of SLC12A7 in inner ear hair cells |
| What is the role of KCC1 in red blood cell volume? | Knockout of SLC12A4 in erythroid cells |
How to Study the potassium:chloride symporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Membrane potential and Cl- currents | Assessing KCC2 function in neurons |
| Ion flux assay with 86Rb+ | K+ transport rate | Quantifying K+:Cl- symport activity in cells |
| Phospho-specific Western blot | Phosphorylation status of transporter | Detecting PKC-mediated regulation of KCC2 |
| Immunofluorescence | Subcellular localization of transporter | Studying surface expression and trafficking |
| CRISPR knockout | Loss-of-function phenotype | Determining gene necessity in cell models |
| CRISPR knock-in | Effect of specific mutations | Modeling disease-associated variants |
| RNA-seq | Transcriptional changes | Identifying compensatory mechanisms after knockout |
| Proteomics | Protein interactions and modifications | Mapping the K+:Cl- symporter interactome |
Electrophysiology
Patch-clamp recordings and ion-sensitive microelectrodes can measure the transport activity of K+:Cl- symporters by monitoring changes in intracellular Cl- concentration or membrane potential. These methods are particularly useful in neurons to assess the functional impact of KCC2 modulation.
Phosphorylation Assays
Western blotting with phospho-specific antibodies and in vitro kinase assays can detect phosphorylation of K+:Cl- symporters, such as PKC-dependent phosphorylation of KCC2. These techniques help elucidate regulatory pathways.
Ion Flux Measurements
Radioactive tracer flux assays using 86Rb+ (a K+ analog) or 36Cl- can quantify the rate of K+:Cl- symport in cells and membrane vesicles. This method provides direct measurement of transport activity.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 can generate knockout, point mutation, and knock-in models to study the function of K+:Cl- symporter genes in vitro and in vivo. These models are essential for linking specific genes to physiological and pathological outcomes.
How CRISPR Can Be Used to Study GO:0015379 potassium:chloride symporter activity
Knockout
CRISPR-Cas9 knockout of genes encoding K+:Cl- symporters, such as SLC12A5 (KCC2), can abolish transport activity and reveal its role in neuronal inhibition and cell volume regulation. Knockout models are valuable for studying loss-of-function phenotypes and for validating drug targets.
Point Mutation
Introducing point mutations that mimic or prevent phosphorylation (e.g., in KCC2) allows researchers to dissect the regulatory role of specific residues. CRISPR-based point mutation is ideal for studying post-translational modifications and disease-associated missense variants.
Knock-in
Knock-in of patient-derived mutations or epitope tags into endogenous loci provides physiological expression levels and context. This approach is useful for modeling diseases linked to K+:Cl- symporter dysfunction and for tracking protein localization.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression constructs can increase K+:Cl- symporter levels to study gain-of-function effects and rescue experiments. Overexpression of KCC2, for example, can enhance inhibitory neurotransmission.
How EDITGENE Supports potassium:chloride symporter activity Research
Researchers studying potassium:chloride symporter activity-related genes often need to determine whether a candidate gene is causally involved in a specific physiological or pathological process. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies of GO:0015379 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for potassium:chloride symporter activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC12A4 Knockout HEK293 Cell Line | EDJ-KQ5783 | Human | 6560 | Details Get a Quote |
| SLC12A6 Knockout HEK293 Cell Line | EDC07899 | Human | 9990 | Details Get a Quote |
| SLC12A7 Knockout HEK293 Cell Line | EDJ-KQ7141 | Human | 10723 | Details Get a Quote |
| SLC12A8 Knockout HEK293 Cell Line | EDJ-KQ10120 | Human | 84561 | Details Get a Quote |
| SLC12A5 Knockout HEK293 Cell Line | EDJ-KQ15294 | Human | 57468 | Details Get a Quote |
| SLC12A9 Knockout HEK293 Cell Line | EDJ-KQ15295 | Human | 56996 | Details Get a Quote |
| SLC12A9 Knockout HeLa Cell Line | EDJ-KQ17945 | Human | 56996 | Details Get a Quote |
| SLC12A4 Knockout A-549 Cell Line | EDJ-KQ29203 | Human | 6560 | Details Get a Quote |
| SLC12A4 Knockout HCT 116 Cell Line | EDJ-KQ29204 | Human | 6560 | Details Get a Quote |
| SLC12A7 Knockout A-549 Cell Line | EDJ-KQ32030 | Human | 10723 | Details Get a Quote |
| SLC12A7 Knockout HCT 116 Cell Line | EDJ-KQ32031 | Human | 10723 | Details Get a Quote |
| SLC12A7 Knockout HeLa Cell Line | EDJ-KQ32032 | Human | 10723 | Details Get a Quote |
| SLC12A8 Knockout A-549 Cell Line | EDJ-KQ37215 | Human | 84561 | Details Get a Quote |
| SLC12A8 Knockout HCT 116 Cell Line | EDJ-KQ37216 | Human | 84561 | Details Get a Quote |
| SLC12A5 Knockout A-549 Cell Line | EDJ-KQ45993 | Human | 57468 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About potassium:chloride symporter activity
What is potassium:chloride symporter activity?
Potassium:chloride symporter activity (GO:0015379) is a molecular function that enables the coupled, electroneutral transport of one potassium ion and one chloride ion across a membrane, typically into the cell.
What genes are involved in potassium:chloride symporter activity?
The main genes encoding K+:Cl- symporters are SLC12A4 (KCC1), SLC12A5 (KCC2), SLC12A6 (KCC3), and SLC12A7 (KCC4), all members of the SLC12A family of cation-chloride cotransporters.
How is potassium:chloride symporter activity regulated?
It is regulated by phosphorylation, particularly by protein kinase C (PKC), which can reduce the surface stability and activity of transporters like KCC2. Other kinases such as WNK and SPAK/OSR1 also play roles.
What diseases are associated with potassium:chloride symporter dysfunction?
Dysfunction is linked to neurological disorders such as epilepsy and neuropathic pain, as well as hypertension and renal disorders.
What is the role of KCC2 in neurons?
KCC2 (SLC12A5) maintains low intracellular chloride in mature neurons, which is essential for fast inhibitory neurotransmission mediated by GABA and glycine.
How can CRISPR be used to study potassium:chloride symporter activity?
CRISPR can generate knockout, point mutation, and knock-in models to test the function of K+:Cl- symporter genes in cells and animals, revealing their roles in physiology and disease.
What methods measure potassium:chloride symporter activity?
Common methods include patch-clamp electrophysiology, radioactive ion flux assays, phosphorylation assays, and immunofluorescence for localization.
Is potassium:chloride symporter activity electroneutral?
Yes, because it transports one K+ and one Cl- ion together, the net charge movement is zero, making it electroneutral.
What is the difference between K+:Cl- symporters and Na+-K+-2Cl- cotransporters?
K+:Cl- symporters (KCCs) transport only K+ and Cl-, while Na+-K+-2Cl- cotransporters (NKCCs) also move Na+ and are not classified under GO:0015379.
Can potassium:chloride symporter activity be targeted therapeutically?
Yes, modulating K+:Cl- symport activity is a potential strategy for treating conditions like epilepsy, neuropathic pain, and hypertension, although specific drugs are still under investigation.
Conclusion
Potassium:chloride symporter activity (GO:0015379) is a fundamental molecular function that governs ion homeostasis, cell volume, and neuronal inhibition. The SLC12A family of K+:Cl- cotransporters, particularly KCC2, plays critical roles in health and disease, with dysregulation linked to neurological and renal disorders. Advances in CRISPR-based genome editing and functional assays are accelerating our understanding of these transporters and opening new avenues for therapeutic intervention. Continued research into the regulation and physiological roles of K+:Cl- symporters will be essential for translating these insights into clinical benefits.
References
- 1. Jaggi AS et al.. 2015. Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases.. Curr Neuropharmacol 13(3):369-88 PMID: 26411965
- 2. Lee HH et al.. 2007. Direct protein kinase C-dependent phosphorylation regulates the cell surface stability and activity of the potassium chloride cotransporter KCC2.. J Biol Chem 282(41):29777-84 PMID: 17693402
- 3. Hebert SC. 1999. Molecular mechanisms.. Semin Nephrol 19(6):504-23 PMID: 10598539
- 4. Docker A et al.. 2022. Selective Potassium Chloride Recognition, Sensing, Extraction, and Transport Using a Chalcogen-Bonding Heteroditopic Receptor.. J Am Chem Soc 144(32):14778-14789 PMID: 35930460
- 5. Ramsay LE et al.. 1980. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.. Clin Pharmacol Ther 27(4):533-43 PMID: 7357812
- 6. Müller V et al.. 2003. Metabolism of chloride in halophilic prokaryotes.. Extremophiles 7(4):261-6 PMID: 12728360
- 7. Friedrich B et al.. 2006. Cell volume regulatory mechanisms.. Contrib Nephrol 152:1-8 PMID: 17065804
- 8. Ohana E. 2015. Transepithelial ion transport across duct cells of the salivary gland.. Oral Dis 21(7):826-35 PMID: 24164806
